48 results on '"Kusstatscher, S"'
Search Results
2. Role of Basic Fibroblast Growth Factor (bFGF) and Platelet-Derived Growth Factor (PDGF) in Ulcer Healing
3. The Effect of bFGF and PDGF on Acute Gastric Mucosal Lesions, Chronic Gastritis and Chronic Duodenal Ulcer
4. Mechanisms of ammonia-induced gastric mucosal injury: role of glutathione and cysteine proteases
5. Die Rolle der Angiogenese und des Wachstumsfaktors bFGF bei der Ulkusheilung und der Behandlung der Gastritis
6. Role of bFGF and Angiogenesis in Ulcer Healing and the Treatment of Gastritis
7. Low dose of clarithromycin in triple therapy for the eradication of Helicobacter pylori: One or two weeks?
8. Helicobacter pylori eradication and serum pepsinogens
9. Helicobacter pylori (Hp) eradication in functional dyspepsia: A prospective randomized 3 years study
10. Quadruple therapy versus ranitidine bismuth citrate after failure of standard triple therapy
11. Update on Helicobacter pylori research. Eradication
12. Helicobacter pylori eradication in functional dyspepsia: A prospective randomized six months study
13. The prevalence of esophagitis in patients with duodenal ulcer after eradication of Helicobacter pylori (Hp) infection: One year follow-up
14. One year prospective multicenter study after eradication in Helicobacter pylori positive gastric ulcer disease
15. Two different approaches after failure of standard H-pylori eradication triple therapies
16. H-pylori eradication in gastric ulcer disease: One year prospective multicenter study
17. Is non ulcer dyspepsia an indication for Helicobacter pylori eradication? A one year prospective study
18. Azithromycin for the cure of Helicobacter pylori infection
19. SERUM PEPSINOGEN-A AND PEPSINOGEN-C LEVELS - A FOLLOW-UP-STUDY ON 476 PATIENTS AFTER HELICOBACTER-PYLORI ERADICATION
20. EARLY DROP IN ANTIHELICOBACTER-PYLORI IGG TITER AFTER ERADICATION THERAPY WITH CLARITHROMYCIN
21. Does Helicobacter pylori infection eradication modify peptic ulcer prevalence?
22. The appearance of gord in patients with duodenal ulcer after eradication of Helicobacter pylori (Hp) infection: A 4 year prospective study
23. Helicobacter pylori (Hp) eradication in functional dyspepsia: A prospective randomized 3 year study
24. Eradication
25. Role of cysteine proteases and protease inhibitors in gastric mucosal damage induced by ethanol or ammonia in the rat.
26. Clarithromycin for the cure of Helicobacter pylori infection: One or two weeks of treatment
27. Serum pepsinogen A and C levels: A follow-up study on 476 patients after Helicobacter pylori eradication
28. Effect of sucralfate on the colonic mucosal hypoxia in the iodoacetamide-induced ulcerative colitis in rats
29. Early drop in anti Helicobacter pylori IgG titre after eradication therapy with clarithromycin
30. Molecular and Cellular Basis of Ulcer Healing
31. Stimulation of Mucosal Glutathione and Angiogenesis: New Mechanisms of Gastroprotection and Ulcer Healing by Sucralfate
32. Growth Factors: New ‘Endogenous Drugs’ for Ulcer Healing
33. Blood pepsinogen as a subclinical marker for duodenal ulcer
34. Low dose of clarithromycin in triple therapy for the eradication of Helicobacter pylori: One or two weeks?
35. Fatal splenic rupture following heimlich maneuver: case report and literature review.
36. Different molecular forms of basic fibroblast growth factor (bFGF) accelerate duodenal ulcer healing in rats.
37. Low dose of clarithromycin in triple therapy for the eradication of Helicobacter pylori: One or two weeks?
38. Impaired fibrinolysis and increased protease levels in gastric and duodenal mucosa of patients with active duodenal ulcer
39. The appearanceof gord in patients with duodenal ulcer after eradication of Helicobacter pylori(Hp) infection: A 4 year prospective study
40. Helicobacter pylori (Hp)eradication in functional dyspepsia: A prospective randomized 3 year study
41. Does Helicobacter pyloriinfection eradication modify peptic ulcer prevalence?
42. Necrotizing fasciitis: case series and review of the literature on clinical and medico-legal diagnostic challenges.
43. Update on Helicobacter pylori research. Eradication.
44. Impaired fibrinolysis and increased protease levels in gastric and duodenal mucosa of patients with active duodenal ulcer.
45. Azithromycin for the cure of Helicobacter pylori infection.
46. [Role of endogenous basic fibroblast growth factor in experimental duodenal ulcer].
47. [The effect of thrombocyte-derived growth factor on experimental inflammatory bowel disease].
48. [Collection, survey and interpretation of pH-metry data].
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.